Table 1.
Clinical characteristics and serum chemistry of the study population.
| Variables | Healthy individuals | Patients with Type 2 diabetes | P-value |
|---|---|---|---|
| Age, y | 55.1 ± 10.4 | 56.3 ± 14.9 | 0.352 |
| Male, n (%) | 13, (43.3%) | 14, (46.7%) | 0.400 |
| BMI, kg/m2 | 23.4 ± 2.32 | 26.5 ± 2.99 | <0.001 |
| FBS, mg/dL | 91.2 ± 7.43 | 154.5 ± 35.0 | <0.001 |
| PP2, mg/dL | 143.7 ± 22.3 | 230.3 ± 89.4 | <0.001 |
| HbA1c, % | 5.61 ± 0.65 | 9.49 ± 1.80 | <0.001 |
| AST, IU/L | 22.0 ± 7.12 | 24.3 ± 13.9 | 0.211 |
| ALT, IU/L | 26.1 ± 8.38 | 29.6 ± 25.3 | 0.235 |
| Total cholesterol, mg/dL | 155.2 ± 39.1 | 175.5 ± 41.5 | 0.028 |
| Triglyceride, mg/dL | 146.7 ± 39.4 | 235.4 ± 161.7 | 0.003 |
| HDL cholesterol, mg/dL | 50.7 ± 12.3 | 44.7 ± 11.5 | 0.029 |
| LDL cholesterol, mg/dL | 91.3 ± 23.4 | 104.8 ± 31.6 | 0.032 |
| Creatinine, mg/dL | 0.78 ± 0.20 | 0.92 ± 0.53 | 0.093 |
| Hx of periodontal disease, n (%) | 5, (16.7%) | 13, (43.3%) | 0.012 |
| Smoking, n (%) | 9, (30%) | 8, (26.7%) | 0.390 |
BMI, body mass index; FBS, fasting blood sugar; PP2, 2-hour postprandial glucose; AST, aspartate transaminase; ALT, alanine transaminase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Hx, history.